Mutant Mosquitoes Deployed to Stop Zika, Dengue

A Brazilian town will ramp up the release of insects engineered to shrink mosquito populations.

kerry grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, EMIL AUGUST GOELDIOxitec, a company that breeds genetically modified (GM) mosquitoes whose offspring die young, is launching a facility in Piracicaba, Brazil, to combat viral infections transmitted by Aedes aegypti mosquitoes. Already, Oxitec had been releasing its mosquitoes in a small region of Piracicaba; the program will now expand to the city center.

“This will bring to the city a new Oxitec factory to meet demand for years to come and help protect the public’s health with this clean and innovative technology,” Mayor Gabriel Ferrato said in a press release.

Oxitec’s program in Piracicaba began in April 2015, and, according to the press release, wild mosquito larvae numbers dropped 82 percent by the end of the year. The mosquitoes are genetically modified so that when mated with wild-type mosquitoes produce larvae that don’t make it to adulthood.

Thomas Scott, who studies vector-borne diseases at the University of California, Davis, said the results from field trials are encouraging. “It will be helpful if future trials can demonstrate disease reduction, determine that the strategy can be scaled-up to modern mega-cities ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours